Information on CYBB

Basic details

Alt. symbols: CGD | GP91-PHOX | NOX2

Approved name: cytochrome b-245 beta chain
Alt. names: chronic granulomatous disease, cytochrome b-245, beta polypeptide | NADPH oxidase 2

Location: Xp21.1: 37780018 - 37813461 (+)
Gene type: protein_coding, 6 transcripts.

Scores: LoFtool: 0.010500 | pLI: 0.99769790 | LOEUF: 0.193

HGNC: 2578

NCBI: 1536, RefSeq: NG_009065.1

Ensembl: ENSG00000165168.9

LRG_53 | Status: public

OMIM: 300481

Expression | ProteinAtlas

Normal function

The CYBB gene encodes the protein NADPH oxidase 2 (Nox2), also known as cytochrome b(558) subunit beta, or cytochrome b-245 beta chain, or p91-phox. This protein is a subunit of the NADPH oxidase enzyme complex, which plays an essential role in the immune system. Within this complex, the cytochrome b-245 beta chain has an alpha chain partner (produced from the CYBA gene). Both alpha and beta chains are required for either to function, and the NADPH oxidase complex requires both chains in order to be functional. NADPH oxidase is primarily active in phagocytes, which attack bacteria and fungi pathogens. NADPH oxidase is also thought to regulate the activity of neutrophils. These cells play a role in adjusting the inflammatory response to optimize healing and reduce injury to the body. The presence of pathogens stimulates phagocytes and triggers the assembly of NADPH oxidase. This enzyme participates in a chemical reaction that converts oxygen to superoxide (toxic). Superoxide is used to generate several other compounds, including hydrogen peroxide and hypochlorous acid. These highly reactive, toxic substances, known as reactive oxygen species, are used by phagocytes to kill invading fungi and bacteria.

Dysfunction and disease

Mutations in the CYBB gene cause x-linked chronic granulomatous disease (CGD) [MIM:306400], but also X-linked Immunodeficiency 34 with mycobacteriosis [MIM:300645] (Bustamante et al., 2011, 2007). The condition primarily affects males as it is inherited in an X-linked recessive manner. Females, who very rarely present one mutated CYBB allele, have mild symptoms of chronic granulomatous disease, such as an increased frequency of bacterial or fungal infections. More than 650 mutations in the CYBB gene have been found to cause chronic granulomatous disease to date. People with this disorder are at increased risk of developing recurrent episodes of infection and inflammation. Mutations in the CYBB gene cause approximately 70 percent of all cases of CGD. Most of these mutations are missense, although nonsense, frameshift and splice-site mutations have also been described. An altered cytochrome b-245 beta subunit not only diminishes its function, but the function of its alpha chain partner as well. Without these subunits, NADPH oxidase cannot assemble or function properly. As a result, phagocytes are unable to produce reactive oxygen species to kill pathogens, and neutrophil activity is not regulated. A lack of NADPH oxidase leaves affected individuals vulnerable to many types of infection and excessive inflammation. [Load More]

[Reviewed by Andrés Caballero-Oteyza on ]

Associated conditions

Acronym Condition's_name MOI Mode_of_actionwww icon OMIM_ID No.cases
CGDX Granulomatous disease, chronic, X-linked XLRdict. icon Loss of Function 306400www icon 0 (0 fams)
IMD34 Immunodeficiency 34 XLRdict. icon Loss of Function 306445www icon 0 (0 fams)

Please mind that full curation (inclusion of all published patients) of this gene has not started yet. Please contact us if you want to volunteer.

Transcripts of CYBB

Name ENSEMBL_ID LRG_ID CCDS_ID MANE Transcript.type Exons Canonical CDS_length REFSEQ_ID
201 ENST00000378588.5 1 CCDS14242 Select protein_coding 13 Yes 4276 NM_000397
204 ENST00000696171.1 protein_coding No XM_047441855

Published variants

Found 0 variants

Var.name Exon/Intron cDNA_pos. CDS_change Prot.change Var.type Var.class. Patients

Please mind that full curation (inclusion of all published variants) of this gene has not started yet. Please contact us if you want to volunteer.

Diagnostic pitfalls & paradigms

Considerations to take into account when analyzing this gene

Year Paradigm ⓘ PMID Notes
- Regions of Homology -
2005Mosaicism15308575[somatic] Authors describe a 66-yo female with clinical symptoms of CGD, who was found to be heterozygous for a p.Y30X mutation in leukocytes. However it was fully expressed in the mRNA. They found out that this was not due to extreme skewing of the X-chromosome but rather to mosaicism because the mutation was absent in cheek mucosal cells and in T cells.
2001Cryptic splicing11435314Reported 3 CGD patients of the same kindred carrying a silent mutation at exon's 3 donor splice site. The mutation led to different splicing patterns of CYBB gene transcripts in patient neutrophils.
2012Mosaicism22305980
2004Cryptic splicing15507763
2023Skewed X-linked inactivation37597073Study reports one girl with XL-CGD who carried a heterozygous exon 13 deletion in CYBB but was affected because of her skewed X-chromosome inactivation.
2019Skewed X-linked inactivation31522453
2018Skewed X-linked inactivation29508720
2001Skewed X-linked inactivation11261321
2002Skewed X-linked inactivation11978610
2003Skewed X-linked inactivation14697745
2008Skewed X-linked inactivation18774749
2007Skewed X-linked inactivation17089090
2008Skewed X-linked inactivation18520120
2015Skewed X-linked inactivation26090111
-Uniparental disomy-Unreported or not recorded in our DB.
-Incomplete penetrance-Unreported or not recorded in our DB.
-Di-/oligo-genic inheritance-Unreported or not recorded in our DB.
-Somatic reversion-Unreported or not recorded in our DB.

References linked to variants in CYBB

ID Year Title Journal PMID Variants

Phenotypic & functional assays available?

Find laboratories offering tests

Check